X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
http://www.gmp-compliance.org/gmp-news/fda-warning-letter-for-inadequate-batch-record-review
http://www.gmp-compliance.org/gmp-news/whos-position-on-the-import-alert-for-a-chinese-api-manufacturers-products
https://www.pharmacompass.com/pdf/news/qinhuangdao-zizhu-pharmaceutical-co-ltd-on-who-public-inspection-report-1499234513.pdf
https://www.pharmacompass.com/pdf/news/qinhuangdao-zizhu-pharmaceutical-receives-fda-warning-letter-1498717322.pdf
http://www.raps.org/Regulatory-Focus/News/2017/06/21/27952/FDA-Warns-Chinese-API-Maker-for-Data-Integrity-Issues/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
https://www.pharmacompass.com/pdf/news/qinhuangdao-zizhu-pharmaceutical-on-health-canada-inspection-list-1497504574.pdf
https://www.pharmacompass.com/pdf/news/who-response-to-the-usfda-import-alert-issued-for-qinhuangdao-zizhu-pharmaceutical-api-manufacturing-site-1492861249.pdf
http://www.in-pharmatechnologist.com/Ingredients/US-ban-for-contraceptive-API-firm-Qinhuangdao-Zizhu-has-WHO-worried
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-19-2017-1492575710.pdf
http://www.fiercepharma.com/regulatory/fda-ban-chinese-company-leaves-who-scrambling-for-contraceptives
Market Place
Share 
